Literature DB >> 20894449

Enflurane analgesia.

S Firn.   

Abstract

An air-enflurane mixture was used for inhalation analgesia in conscious patients undergoing painful procedures such as burns dressings. A preliminary study indicated that enflurane possessed definite analgesic properties, but that the concentration of the air-enflurane mixture was critical if restlessness was to be avoided and cooperation retained. Further studies established that 1% enflurane in air provided good analgesia in the absence of anaesthesia. The analgesic effects were similar to those produced by 0.35% methoxyflurane in air, but were produced in a much shorter time (about 3 minutes compared with 9 to 10 minutes). Preoperative starvation was unnecessary and nausea and vomiting were absent. Details are given of the use of enflurane analgesia in 32 conscious burned patients who underwent 101 burns dressing procedures.

Entities:  

Year:  1982        PMID: 20894449      PMCID: PMC1440496     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  5 in total

1.  Methoxyflurane analgesia for burns dressings: experience with the analgizer.

Authors:  K J Packer; J H Titel
Journal:  Br J Anaesth       Date:  1969-12       Impact factor: 9.166

2.  Analgesia for burns dressing using methoxyflurane.

Authors:  M A Marshall; H P Ozorio
Journal:  Br J Anaesth       Date:  1972-01       Impact factor: 9.166

3.  Methoxyflurane analgesia for burns dressings and other painful ward procedures in children.

Authors:  S Firn
Journal:  Br J Anaesth       Date:  1972-05       Impact factor: 9.166

4.  Intermittent inhalation of methoxyflurane and trichloroethylene as analgesics in burns dressings procedures.

Authors:  S M Laird; B M Gray
Journal:  Br J Anaesth       Date:  1971-02       Impact factor: 9.166

5.  Di-ethyl ether analgesia: a detailed description of the first stage of ether anesthesia in man.

Authors:  J F ARTUSIO
Journal:  J Pharmacol Exp Ther       Date:  1954-07       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.